Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
-
Publication Venue For
-
Identification of a Locus Near ULK1
Associated With Progression-Free Survival in Ovarian Cancer..
30:1669-1680.
2021
-
Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE Trial..
27:783-789.
2018
-
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium..
26:1470-1473.
2017
-
Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database..
25:547-554.
2016
-
Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study..
23:2936-2942.
2014
-
Abstract A30: Using the principles of community-based participatory research to build an office of health equity within a nationally designated cancer institute.
23:A30-A30.
2014
-
Abstract B22: Altered methylation profiles of imprinted genes in response to prenatal exposure to cigarette smoke in the Newborn Epigenetic STudy (NEST) cohort.
23:B22-B22.
2014
-
Abstract C16: Feasibility study: Protein profiling of primary breast cancers from premenopausal women.
23:C16-C16.
2014
-
Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database..
23:2349-2356.
2014
-
Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial..
23:1944-1947.
2014
-
Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer..
20:2438-2449.
2011
-
Mathematical modeling predicts the effect of folate deficiency and excess on cancer-related biomarkers..
20:1912-1917.
2011
-
A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1..
20:1078-1088.
2011
-
Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study..
18:1953-1961.
2009
-
Dietary patterns, food groups, and rectal cancer risk in Whites and African-Americans..
18:1552-1561.
2009
-
Marijuana smoking and the risk of head and neck cancer: pooled analysis in the INHANCE consortium..
18:1544-1551.
2009
-
Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study..
18:1379-1385.
2009
-
Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls..
18:1232-1238.
2009
-
Human biospecimen research: experimental protocol and quality control tools..
18:1017-1025.
2009
-
Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk..
18:935-944.
2009
-
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium..
18:541-550.
2009
-
Race/ethnicity, physical activity, and quality of life in breast cancer survivors..
18:656-663.
2009
-
Association and interactions between DNA repair gene polymorphisms and adult glioma..
18:204-214.
2009
-
Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer..
18:28-34.
2009
-
Urinary isothiocyanates; glutathione S-transferase M1, T1, and P1 polymorphisms; and risk of colorectal cancer: the Multiethnic Cohort Study..
18:314-320.
2009
-
Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer..
17:3467-3473.
2008
-
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery..
17:3577-3587.
2008
-
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women..
17:3567-3572.
2008
-
Breast cancer survival among economically disadvantaged women: the influences of delayed diagnosis and treatment on mortality..
17:2882-2890.
2008
-
Comparing the reliability of responses to telephone-administered versus self-administered Web-based surveys in a case-control study of adult malignant brain cancer..
17:2639-2646.
2008
-
Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique..
17:2350-2355.
2008
-
ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention..
17:1884-1890.
2008
-
Involuntary smoking and head and neck cancer risk: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium..
17:1974-1981.
2008
-
Cyclin E overexpression relates to ovarian cancer histology but not to risk factors..
17:1841.
2008
-
Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis..
17:1822-1831.
2008
-
Performance of amplified DNA in an Illumina GoldenGate BeadArray assay..
17:1781-1789.
2008
-
The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis..
17:1739-1745.
2008
-
DNA repair capacity and lung cancer risk in never smokers..
17:1322-1328.
2008
-
Differences in baseline characteristics and outcomes at 1- and 2-year follow-up of cancer survivors accrued via self-referral versus cancer registry in the FRESH START Diet and exercise trial..
17:1288-1294.
2008
-
Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup..
17:585-593.
2008
-
Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium..
17:484-489.
2008
-
Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer..
17:397-404.
2008
-
Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ..
16:2587-2593.
2007
-
Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk..
16:2756-2762.
2007
-
Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer..
16:2379-2386.
2007
-
GLIOGENE an International Consortium to Understand Familial Glioma..
16:1730-1734.
2007
-
Oral contraceptives and survival in breast cancer patients aged 20 to 54 years..
16:1822-1827.
2007
-
Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck..
16:1633-1638.
2007
-
Common variation in the BRCA1 gene and prostate cancer risk..
16:1510-1516.
2007
-
Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study..
16:1356-1363.
2007
-
Association between germline variation in the FHIT gene and prostate cancer in Caucasians and African Americans..
16:1294-1297.
2007
-
Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention..
16:1032-1034.
2007
-
Dietary mutagen exposure and risk of pancreatic cancer..
16:655-661.
2007
-
Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology..
16:613-616.
2007
-
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer..
16:473-480.
2007
-
In situ assessment of intraepithelial neoplasia in hamster trachea epithelium using angle-resolved low-coherence interferometry..
16:223-227.
2007
-
Pooling of case specimens to create standard serum sets for screening cancer biomarkers..
16:334-341.
2007
-
Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk..
16:50-56.
2007
-
Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites..
15:2364-2369.
2006
-
Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis..
15:2526-2532.
2006
-
Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers..
15:1703-1707.
2006
-
Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population..
15:1336-1340.
2006
-
Barriers to full colon evaluation for a positive fecal occult blood test..
15:1232-1235.
2006
-
DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset..
15:886-891.
2006
-
Mathematical modeling: epidemiology meets systems biology..
15:827-829.
2006
-
Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer..
15:935-938.
2006
-
APC I1307K and the risk of prostate cancer..
15:468-473.
2006
-
Combined effects of the p53 and p73 polymorphisms on lung cancer risk..
15:158-161.
2006
-
Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women..
14:3013-3014.
2005
-
Interest in testing for genetic susceptibility to lung cancer among Black college students "at risk" of becoming cigarette smokers..
14:2978-2981.
2005
-
Estrogen bioactivation, genetic polymorphisms, and ovarian cancer..
14:2536-2543.
2005
-
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort..
14:2413-2418.
2005
-
Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck..
14:1961-1966.
2005
-
Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta..
14:2035-2039.
2005
-
The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori..
14:1883-1889.
2005
-
XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies..
14:1810-1818.
2005
-
5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer..
14:1470-1476.
2005
-
Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer..
14:1557-1561.
2005
-
Project PREVENT: a randomized trial to reduce multiple behavioral risk factors for colon cancer..
14:1453-1459.
2005
-
Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms..
14:1477-1484.
2005
-
Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis..
14:1188-1193.
2005
-
Response rates to a mailed survey targeting childhood cancer survivors: a comparison of conditional versus unconditional incentives..
14:1330-1332.
2005
-
CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck..
14:1034-1036.
2005
-
Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk..
14:821-825.
2005
-
Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration..
14:790-798.
2005
-
Safety and efficacy of weekly oral oltipraz in chronic smokers..
14:892-899.
2005
-
The biology of tobacco and nicotine: bench to bedside..
14:764-767.
2005
-
IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men..
14:403-408.
2005
-
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers..
13:2141-2147.
2004
-
Racial differences in enrolment in a cancer genetics registry..
13:1349-1354.
2004
-
No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck..
13:1081-1083.
2004
-
Modifying attributions of colorectal cancer risk..
13:560-566.
2004
-
High-throughput detection of glutathione s-transferase polymorphic alleles in a pediatric cancer population..
13:304-313.
2004
-
Association between low dietary folate intake and suboptimal cellular DNA repair capacity..
12:963-969.
2003
-
Dietary folate intake and lung cancer risk in former smokers: a case-control analysis..
12:980-986.
2003
-
Genetic susceptibility to lung cancer: the role of DNA damage and repair..
12:689-698.
2003
-
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina..
12:226-227.
2003
-
Correspondence re: Zheng et al, Haplotype of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. 11: 640-645, 2002..
12:71.
2003
-
DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma..
11:1142-1143.
2002
-
Environmental factors in relation to breast cancer characterized by p53 protein expression..
11:829-835.
2002
-
Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study..
11:640-645.
2002
-
The impact of item order on ratings of cancer risk perception..
11:654-659.
2002
-
Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income..
11:521-528.
2002
-
Communicating breast cancer risks to women using different formats..
10:895-898.
2001
-
Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000..
10:415-416.
2001
-
PTEN polymorphism (IVS4) is not associated with risk of prostate cancer..
10:411-412.
2001
-
Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study..
10:397-401.
2001
-
Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx..
10:273-275.
2001
-
Relationships among breast cancer perceived absolute risk, comparative risk, and worries..
9:973-975.
2000
-
The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer..
9:439-442.
2000
-
Early onset baldness and prostate cancer risk..
9:325-328.
2000
-
Increased weight & body fatness associated with chemotherapy for breast cancer ... & what can be done?.
9:236-236.
2000
-
Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction..
8:801-807.
1999
-
Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer..
8:533-539.
1999
-
Environmental contaminants and body fat distribution..
8:179-183.
1999
-
Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status..
7:483-488.
1998
-
Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas..
7:553-555.
1998
-
Reduced DNA repair capacity in head and neck cancer patients..
7:465-468.
1998
-
Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk..
7:371-378.
1998
-
Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer..
7:309-314.
1998
-
Relationships among objective and subjective risk for breast cancer and mammography stages of change..
5:1005-1011.
1996
-
Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia..
5:639-644.
1996
-
The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer..
5:329-335.
1996
-
Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection..
4:715-720.
1995
-
Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry..
3:597-605.
1994
-
Vitamin D and prostate cancer: a prediagnostic study with stored sera..
2:467-472.
1993
-
Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis..
2:329-333.
1993
-
Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients..
2:103-106.
1993
-
Identification of women at increased risk for breast cancer in a population-based screening program..
1:143-147.
1992
-
Abstract SS02-02: A long walk from FGFR2 alternative splicing to cancer progression.
23.
2014
-
Abstract PO-183: Racial disparities in Helicobacter pylori
infection: A systematic review and retrospective study
2022
-
Abstract PO-232: Racial differences in the tumor immune landscape and survival of high-grade serous ovarian carcinoma
2022
-
Abstract 101: The Tanzanian Pediatric Cancer Network: A Comprehensive Evaluation of the Incidence of Presenting Patients and Access to Pediatric Cancer Care in Tanzania
2021
-
Abstract 102: Breakpoints in Protocol Compliance and Their Influence on Outcomes for Children with Wilms Tumor in Northern Tanzania
2021
-
Abstract 112: Use of WhatsApp to Improve Medical Provider Communication for Children with Wilms Tumor in Tanzania
2021
-
Abstract 4: Impact of Immunohistochemistry on Diagnostic Accuracy for Pediatric Cancer in Tanzania
2021
-
Abstract A023: Results from a town hall meeting: Inflammatory breast cancer listening session led by KOMEN scholars
2020
-
Abstract A038: Current unmet needs in inflammatory breast cancer/IBC patient care: Analysis of open-ended responses from a community engagement session of clinicians, researchers, advocates, and patients at the Duke Consortium for IBC conference
2020
-
Abstract A043: Cancer care in people with HIV: Identifying adherence challenges to improve outcomes
2020
-
Abstract A066: Performance of the prostate health index (PHI) assay in black men
2020
-
Abstract A076: Adherence to adjuvant endocrine therapy: Do racial disparities persist among the insured?
2020
-
Abstract A080: Rates of Invitation, participation, and willingness to engage in medical and clinical research: Findings from attendees at two gender-specific community-based screening programs
2020
-
Abstract A082: ENACT: A randomized trial assessing the impact of the Oncotype DX Prostate Cancer Assay on treatment decision in a racially diverse population of men eligible for active surveillance
2020
-
Abstract A114: Characterization of a metastatic prostate cancer xenograft derived from a patient of African ancestry
2020
-
Abstract B006: Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
2020
-
Abstract B034: Improving patient-centered care for inflammatory breast cancer: Strategies for addressing barriers faced by patients, researchers, and providers
2020
-
Abstract B035: Identification of a tumor cell adaptive stress response signaling pathway, which drives aggressive breast cancer phenotype and therapeutic resistance, in African American patients with locally advanced breast cancer subtypes
2020
-
Abstract B050: Identification of differentially expressed and spliced genes between breast, colon, lung, and prostate cancer from African American and white patients
2020
-
Abstract B061: Mechanistic and functional interrogation of novel ancestry-related alternatively spliced androgen receptor signal genes in prostate cancer
2020
-
Abstract B063: Race-related LMO7
exon skipping enhances prostate tumor invasion
2020
-
Abstract B064: Race-related genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer
2020
-
Abstract B071: Genomic differences between non-small cell lung cancer (NSCLC) in African American and white patients
2020
-
Abstract B088: Health insurance status, stage at presentation and survival among female patients with head and neck cancer
2020
-
Abstract C007: Racial differences in feasibility and perceived value of electronic symptom monitoring in a cohort of Black and White bladder and prostate cancer patients
2020
-
Abstract C038: First- and second-degree family history of ovarian and breast cancers in relation to risk of invasive ovarian cancer in African American and White women
2020
-
Abstract C044: Dietary inflammatory potential prior to diagnosis and risk of all-cause mortality among African-American women with ovarian carcinoma
2020
-
Abstract C070: Racial disparities in body mass index and ovarian cancer risk in the OCWAA Consortium
2020
-
Abstract D010: Developing an inflammatory breast cancer campaign: Results from focus groups led by Komen scholars
2020
-
Abstract D064: Race-related RNA splicing dysregulation of PI3Kd signaling: A therapeutic target for aggressive prostate cancer
2020
-
Abstract D071: Impact of racial differences in financial burden on time to treatment
2020
-
Abstract D084: Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC)—final PROCEED analysis
2020
-
Abstract D093: Who carries the excess cancer risk burden: Implications of disparities in polycyclic aromatic hydrocarbon exposure
2020
-
Abstract IA18: North Carolina Central University and Duke Cancer Institute's collaborative cancer research and education program: Connecting cancer disparities translational research, clinical trials operations, and community engagement
2020
-
Abstract PR11: Racial differences in characteristics of early- vs. late-onset colorectal cancer among veterans
2020
-
Adherence to adjuvant endocrine therapy: Do racial disparities persist among the insured?
2020
-
Current unmet needs in inflammatory breast cancer/IBC patient care: Analysis of open-ended responses from a community engagement session of clinicians, researchers, advocates, and patients at the Duke Consortium for IBC conference
2020
-
Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer
2020
-
Dietary inflammatory potential prior to diagnosis and risk of all-cause mortality among African-American women with ovarian carcinoma
2020
-
Dietary inflammatory potential prior to diagnosis and risk of all-cause mortality among African-American women with ovarian carcinoma
2020
-
Genomic differences between non-small cell lung cancer (NSCLC) in African American and white patients
2020
-
Identification of differentially expressed and spliced genes between breast, colon, lung, and prostate cancer from African American and white patients
2020
-
Mechanistic and functional interrogation of novel ancestry-related alternatively spliced androgen receptor signal genes in prostate cancer
2020
-
Racial differences in characteristics of early- vs. late-onset colorectal cancer among veterans
2020
-
Rates of Invitation, participation, and willingness to engage in medical and clinical research: Findings from attendees at two gender-specific community-based screening programs
2020
-
Results from a town hall meeting: Inflammatory breast cancer listening session led by KOMEN scholars
2020
-
Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a United States Prospective Cohort Consortium
2020
-
Attitudes, perceptions, and strategies toward increasing cancer screening, treatment, and participation in research among Latinos.
2018
-
Determinants of delays in care-seeking for ovarian cancer symptoms in African American women.
2018
-
Developing effective community and health system partnerships to advance health equity and health disparities research.
2018
-
Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer.
2018
-
Efficacy of GLI antagonists in triple-negative inflammatory breast cancer 2D and 3D models
2018
-
Establishment of African American prostate cancer patient-derived primary cell lines and xenografts.
2018
-
Nutritional profiling reveals glutamine-utilizing transaminases as a metabolic vulnerability of TAZ/YAP-driven breast cancer cells
2018
-
Race-related differential splicing of the insulin receptor: A novel target underlying prostate cancer disparities
2018
-
Abstract B44: Immune pathway dysregulations in inflammatory breast cancer health disparity
2017
-
Abstract B51: Dairy, calcium, vitamin D and ovarian cancer risk in African-American women
2017
-
Abstract B58: Single-nucleotide polymorphisms of race-related alternatively spliced genes associate with prostate cancer risk, aggressiveness and/or survival
2017
-
Abstract B78: The interplay between smoking at diagnosis, marital status, and head and neck cancer survivorship
2017
-
Abstract B79: Disparities in HPV vaccine initiation and completion based on sexual orientation among women in the United States
2017
-
Abstract A51: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine in a national sample of U.S. adults
2016
-
Abstract A52: Sociodemographic predictors of HPV and HPV vaccine knowledge and awareness among Americans who use the Internet as their primary source of health information
2016
-
Abstract A60: A paradox: Engaging in at-risk behavior may not correlate with perceived susceptibility to cancer or heart disease
2016
-
Abstract A73: Obesity, weight gain, and ovarian cancer risk in African American women
2016
-
Abstract B18: Development of novel therapeutic splice-switching oligonucleotides against aggressive prostate cancer in men of African descent
2016
-
Abstract B40: Rare variant discovery in known cancer genes from whole-exome sequencingof African American hereditary prostate cancer families
2016
-
Abstract B58: Assessing university students' sexual risk behavior, knowledge of the human papillomavirus, (HPV), HPV vaccine, and association between HPV and head and neck cancer
2016
-
Abstract B70: Characteristics, risk perception, and predictors of oral cancer knowledge among drag racers and their fans
2016
-
Abstract B89: HPV is not just a woman's business! Understanding the gaps in men's knowledge of HPV and HPV vaccine
2016
-
Abstract C47: Gender and racial disparities in long-term survival of oral and oropharyngeal cancer in the United States
2016
-
Abstract IA09: Intervening on the financial toxicity of cancer care
2016
-
Abstract PR05: Dietary quality and ovarian cancer risk in African American women
2016
-
Acculturation and Ethnic Variations in Breast Cancer Risk Factors, Gail Model Risk Estimates and Mammographic Breast Density
2015
-
Predictors of Colorectal Cancer Surveillance among Radiation-treated Survivors of Childhood Cancer
2013
-
Abstract B35: Altered DNA methylation at imprinted insulin-like growth factor-2 (IGF2) resulting from heavy metal exposure in vitro and in vivo in infants from the Newborn Epigenetic STudy (NEST).
2012
-
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
2005
-
Supplemental vitamin E increases biomarkers of estrogen stimulation in random core breast biopsies of women taking tamoxifen
2005
-
Childhood cancer survivors: Health behaviors and receptivity to health promotion interventions.
2004
-
Screening for therapy-related second cancers.
2004
-
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.
2004
-
Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer.
2003
-
Imsulin-like growth factor-1 (IGF-1): An exploration of serum levels, binding protein (IGFBP-3) and IGF-1 CA repeat genotype, and the risk of prostae cancer
2003
-
A case-control study of candidate ovarian cancer susceptibility polymorphisms.
2002
-
Effects of a low fat, flaxseed-supplemented diet on men with prostatic intraepithelial neoplasia (PIN) or atypia.
2002
-
Evaluation of ovarian cancer preventive agents in the chicken.
2002
-
Randomized controlled clinical trial of weekly oltipraz in smokers.
2002